Coagulation

As an in vitro diagnostics (IVD) market, China ranks just behind the large, developed economies of the United States, Western Europe, and Japan. The Chinese healthcare system faces challenges similar to those in less developed countries, alongside burdens common in affluent countries such as diabetes, cardiovascular disease, and aging-related diseases. China’s potential as an IVD…

Description:

Kalorama Information’s latest edition of our comprehensive in vitro diagnostic market report is now available. For the fourteenth time in two decades, our analysts have meticulously reassessed and updated the in vitro diagnostic market data. The COVID-19 pandemic underscored the critical importance of testing in an unprecedented way. In 2021, COVID-19 testing has become…

Latin America (LATAM) presents significant expansion opportunities for in vitro diagnostic (IVD) manufacturers. Kalorama Information’s latest report focuses on the market for reagents and instruments across key LATAM countries, including Argentina, Brazil, Chile, Colombia, Mexico, Peru, and Venezuela. Additionally, the report covers Bolivia, Costa Rica, Cuba, Dominican Republic, Ecuador, El Salvador, Guatemala, Guyana, Haiti, Honduras,…

Molecular diagnostics is a rapidly evolving and dynamic field, representing the fastest-growing segment within the in vitro diagnostics (IVD) market. It has become an indispensable tool in clinical medicine, influencing various aspects of healthcare such as early identification of antimicrobial resistant (AMR) infections, companion diagnostics for cancer treatment, pharmacokinetics for HIV, psychiatric conditions, and blood…

Kalorama Information presents the Clinical Laboratory Services Market, 6th Edition, a comprehensive analysis of the clinical laboratory industry and the trends fueling its growth. This report offers detailed statistics and insights into the factors influencing the industry, including disease incidence in the U.S. and worldwide demographics, life expectancy, and strategic initiatives by major companies.

 

…

Kalorama Information’s United States Market for In Vitro Diagnostic (IVD) Tests, 3rd Edition provides a comprehensive and insightful analysis of the IVD market in the U.S. This market, the largest in the world, is undergoing significant changes influenced by various factors, including the profound impact of COVID-19.

Market Dynamics:

Explore the current state and…

Diagnostic test products have never been more critical. Kalorama Information’s report, 2021 IVD Market Update and COVID-19 Impact, provides an updated analysis of the in vitro diagnostics (IVD) market, reflecting the latest information from our analysts. This comprehensive report includes market sizing for various IVD categories and examines the major trends and impacts of COVID-19…

In vitro diagnostic (IVD) test volumes are crucial for assessing market opportunities for new entrants with diagnostic products and beneficial for existing product marketers. Kalorama’s In Vitro Diagnostic (IVD) Procedure Volumes, 2020-2025 delivers comprehensive market analysis, saving time with detailed calculations and estimates for the current and future number of diagnostic tests across multiple categories.…

HbA1c testing has become a critical component in the detection and monitoring of diabetes, leading to a highly competitive and rapidly growing market within the in vitro diagnostics (IVD) industry. With increasing global expenditures on both professional and self-testing HbA1c assays, the market is flourishing. Over a dozen companies are actively producing analyzers, reagents, workstations,…